메뉴 건너뛰기




Volumn 59, Issue 2, 2000, Pages 110-117

Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients: A single-center study

Author keywords

Carboplatin; Chemotherapy; Germ cell tumors; Risk adapted therapy

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; MESNA; TUMOR MARKER;

EID: 0033828229     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012146     Document Type: Article
Times cited : (7)

References (32)
  • 1
    • 0030857028 scopus 로고    scopus 로고
    • Testicular germ-cell cancer
    • Bosl GJ, Motzer RJ: Testicular germ-cell cancer. N Engl J Med 1997;337:242-253.
    • (1997) N Engl J Med , vol.337 , pp. 242-253
    • Bosl, G.J.1    Motzer, R.J.2
  • 2
    • 0024555713 scopus 로고
    • Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group Protocol
    • Einhorn LH, Williams SD, Loehrer PJ, Birch R, Drasga R, Omura G, Greco FA: Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group Protocol. J Clin Oncol 1989;7:387-391.
    • (1989) J Clin Oncol , vol.7 , pp. 387-391
    • Einhorn, L.H.1    Williams, S.D.2    Loehrer, P.J.3    Birch, R.4    Drasga, R.5    Omura, G.6    Greco, F.A.7
  • 3
    • 0031894195 scopus 로고
    • Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indiana University experience
    • Saxman SB, Finch D, Gonin R, Einhorn LH: Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indiana University experience. J Clin Oncol 1989;16:702-706.
    • (1989) J Clin Oncol , vol.16 , pp. 702-706
    • Saxman, S.B.1    Finch, D.2    Gonin, R.3    Einhorn, L.H.4
  • 6
    • 0023221275 scopus 로고
    • Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: Results from a European Organisation for Research on Treatment of Cancer multinstitutional phase III study
    • Stoter G, Sylvester R, Sleijfer DT, Huinik WW, Kaye SB, Jones WG, van Oosterom AT, Vendrik CPJ, Spaander P, de Pauw M: Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: Results from a European Organisation for Research on Treatment of Cancer multinstitutional phase III study. Cancer Res 1987; 47:2714-2718.
    • (1987) Cancer Res , vol.47 , pp. 2714-2718
    • Stoter, G.1    Sylvester, R.2    Sleijfer, D.T.3    Huinik, W.W.4    Kaye, S.B.5    Jones, W.G.6    Van Oosterom, A.T.7    Vendrik, C.P.J.8    Spaander, P.9    De Pauw, M.10
  • 8
    • 0031037241 scopus 로고    scopus 로고
    • International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers
    • International Germ Cell Classification Consensus Group: International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.
    • (1997) J Clin Oncol , vol.15 , pp. 594-603
  • 10
    • 0026083732 scopus 로고
    • Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors
    • Horwich A, Dearnaley DP, Nicholls J, Jay G, Mason M, Harland S, Peckham MJ, Hendry WF: Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. J Clin Oncol 1991; 9:62-69.
    • (1991) J Clin Oncol , vol.9 , pp. 62-69
    • Horwich, A.1    Dearnaley, D.P.2    Nicholls, J.3    Jay, G.4    Mason, M.5    Harland, S.6    Peckham, M.J.7    Hendry, W.F.8
  • 13
    • 0023695848 scopus 로고
    • Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide
    • Loehrer PJ, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH: Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 1988;109:540-546.
    • (1988) Ann Intern Med , vol.109 , pp. 540-546
    • Loehrer, P.J.1    Lauer, R.2    Roth, B.J.3    Williams, S.D.4    Kalasinski, L.A.5    Einhorn, L.H.6
  • 14
    • 0027057141 scopus 로고
    • Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience
    • Motzer RJ, Bajorin DF, Vlamis V, Weisen S, Bosl GJ: Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience. Semin Oncol 1992;19(suppl 12):8-12.
    • (1992) Semin Oncol , vol.19 , Issue.SUPPL. 12 , pp. 8-12
    • Motzer, R.J.1    Bajorin, D.F.2    Vlamis, V.3    Weisen, S.4    Bosl, G.J.5
  • 16
    • 0023950092 scopus 로고
    • Comparison of criteria for assigning germ cell tumor patients to 'good risk' and 'poor risk' studies
    • Bajorin D, Katz A, Chan E, Geller N, Vogelzang N, Bosl GJ: Comparison of criteria for assigning germ cell tumor patients to 'good risk' and 'poor risk' studies. J Clin Oncol 1988;6: 786-792.
    • (1988) J Clin Oncol , vol.6 , pp. 786-792
    • Bajorin, D.1    Katz, A.2    Chan, E.3    Geller, N.4    Vogelzang, N.5    Bosl, G.J.6
  • 17
    • 0030939778 scopus 로고    scopus 로고
    • Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic non-seminomatous germ cell cancer: A multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial
    • Horwich A, Sleijfer DT, Fossa SD, Kaye SB, Oliver RTD, Cullen MH, Mead GM, de Wit R, de Mulder PHM, Dearnley DP, Cook PA, Sylvester RJ, Stenning SP: Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic non-seminomatous germ cell cancer: A multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial. J Clin Oncol 1997;15:1844-1852.
    • (1997) J Clin Oncol , vol.15 , pp. 1844-1852
    • Horwich, A.1    Sleijfer, D.T.2    Fossa, S.D.3    Kaye, S.B.4    Oliver, R.T.D.5    Cullen, M.H.6    Mead, G.M.7    De Wit, R.8    De Mulder, P.H.M.9    Dearnley, D.P.10    Cook, P.A.11    Sylvester, R.J.12    Stenning, S.P.13
  • 19
    • 0028860147 scopus 로고
    • Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Oncology Group Trial
    • Loehrer PJ, Johnson D, Elson P, Einhorn LH, Trump D: Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Oncology Group Trial. J Clin Oncol 1995;13:470-476.
    • (1995) J Clin Oncol , vol.13 , pp. 470-476
    • Loehrer, P.J.1    Johnson, D.2    Elson, P.3    Einhorn, L.H.4    Trump, D.5
  • 20
    • 0031005803 scopus 로고    scopus 로고
    • Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group
    • De Wit R, Stoter G, Kaye SB, Sleijfer DT, Jones WG, Huinik WW, Rea LA, Collette L, Sylvester R: Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol 1997;15: 1837-1843.
    • (1997) J Clin Oncol , vol.15 , pp. 1837-1843
    • De Wit, R.1    Stoter, G.2    Kaye, S.B.3    Sleijfer, D.T.4    Jones, W.G.5    Huinik, W.W.6    Rea, L.A.7    Collette, L.8    Sylvester, R.9
  • 21
    • 0030477951 scopus 로고    scopus 로고
    • A randomized trial of cisplatin, etoposide and bleomycin versus carboplatin, etoposide and bleomycin for patients with 'good risk' germ cell tumors
    • Bokemeyer C, Köhrmann O, Tischler J, Weissbach L, Räth U, Haupt A, Schöffski P, Harstrick A, Schmoll HJ: A randomized trial of cisplatin, etoposide and bleomycin versus carboplatin, etoposide and bleomycin for patients with 'good risk' germ cell tumors. Ann Oncol 1996;7:1015-1022.
    • (1996) Ann Oncol , vol.7 , pp. 1015-1022
    • Bokemeyer, C.1    Köhrmann, O.2    Tischler, J.3    Weissbach, L.4    Räth, U.5    Haupt, A.6    Schöffski, P.7    Harstrick, A.8    Schmoll, H.J.9
  • 22
    • 0026548878 scopus 로고
    • The optimisation of carboplatin dose in carboplatin, etoposide and bleomycin combination chemotherapy for good prognosis metastatic non-seminomatous germ cell tumours of testis
    • Childs WJ, Nichols EJ, Horwich A: The optimisation of carboplatin dose in carboplatin, etoposide and bleomycin combination chemotherapy for good prognosis metastatic non-seminomatous germ cell tumours of testis. Ann Oncol 1992;3:291-296.
    • (1992) Ann Oncol , vol.3 , pp. 291-296
    • Childs, W.J.1    Nichols, E.J.2    Horwich, A.3
  • 24
    • 0027475639 scopus 로고
    • Secondary leukemia associated with conventional dose of etoposide: Review of serial germ cell tumor protocols
    • Nichols CR, Breeden ES, Loehrer PJ, Williams SD, Einhorn LH: Secondary leukemia associated with conventional dose of etoposide: Review of serial germ cell tumor protocols. J Natl Cancer Inst 1993;85:36-40.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 36-40
    • Nichols, C.R.1    Breeden, E.S.2    Loehrer, P.J.3    Williams, S.D.4    Einhorn, L.H.5
  • 25
    • 0027406726 scopus 로고
    • Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy
    • Bajorin DF, Motzer RJ, Rodriguez E, Murphy B, Bosl GJ: Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. J Natl Cancer Inst 1993;85:60-62.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 60-62
    • Bajorin, D.F.1    Motzer, R.J.2    Rodriguez, E.3    Murphy, B.4    Bosl, G.J.5
  • 29
    • 0031950313 scopus 로고    scopus 로고
    • Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncolgy Group, and Cancer and Leukemia Group B Study
    • Nichols CR, Catalano PJ, Crawford ED, Vogelzang NJ, Einhorn LH, Loehrer PJ: Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncolgy Group, and Cancer and Leukemia Group B Study. J Clin Oncol 1998;16: 1287-1293.
    • (1998) J Clin Oncol , vol.16 , pp. 1287-1293
    • Nichols, C.R.1    Catalano, P.J.2    Crawford, E.D.3    Vogelzang, N.J.4    Einhorn, L.H.5    Loehrer, P.J.6
  • 30
    • 0031943997 scopus 로고    scopus 로고
    • Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: A Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study
    • Kaye SB, Mead GM, Fossa S, Cullen M, de Wit R, Bodrogi I, van Groeningen C, Sylvester R, Colette L, Stenning S, Prijck L, Lallemand E, de Mulder P: Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: A Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study. J Clin Oncol 1998; 16:692-701.
    • (1998) J Clin Oncol , vol.16 , pp. 692-701
    • Kaye, S.B.1    Mead, G.M.2    Fossa, S.3    Cullen, M.4    De Wit, R.5    Bodrogi, I.6    Van Groeningen, C.7    Sylvester, R.8    Colette, L.9    Stenning, S.10    Prijck, L.11    Lallemand, E.12    De Mulder, P.13
  • 31
    • 0027415652 scopus 로고
    • Management of malignant teratoma: Does referral to a specialist unit matter?
    • Harding MJ, Paul J, Gillis CR, Kaye SB: Management of malignant teratoma: Does referral to a specialist unit matter? Lancet 1993;341: 999-1002.
    • (1993) Lancet , vol.341 , pp. 999-1002
    • Harding, M.J.1    Paul, J.2    Gillis, C.R.3    Kaye, S.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.